Back to search
Childhood Langerhans Cell Histiocytosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Childhood Langerhans Cell Histiocytosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Childhood Langerhans Cell Histiocytosis trials you may qualify forThis study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patient…
A roll-over study to assess long-term effect in pediatric patients treated with dabrafenib and/or trametinib.
CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, i…
Langerhans cell histiocytosis (LCH) of bone is a benign-tumor-like osteolytic lesion in childhood and adolescence, which is characterized by the aberrant activa…
This phase II Pediatric MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in pediatric patients with soli…
This phase I trial studies the side effects and best dose of bevacizumab and temsirolimus alone or in combination with valproic acid or cetuximab in treating pa…